» Articles » PMID: 23680941

Perfluorooctanoate and Neuropsychological Outcomes in Children

Overview
Journal Epidemiology
Specialty Public Health
Date 2013 May 18
PMID 23680941
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In animal studies, perfluorinated compounds affect fetal growth, development, viability, and postnatal growth. The limited epidemiologic findings on child neurobehavioral development are mixed.

Methods: We recruited and evaluated 320 children who participated in the C8 Health Project, a 2005-2006 survey in a Mid-Ohio Valley community highly exposed to perfluorooctanoate (PFOA) through contaminated drinking water. We examined associations among estimated in utero PFOA exposure, measured childhood PFOA serum concentration, and subsequent performance on neuropsychological tests 3-4 years later at ages 6-12 years. We assessed Intelligence Quotient (IQ) reading and math skills, language, memory and learning, visual-spatial processing, and attention. All multivariable linear regression models were adjusted for age, sex, home environment, test examiner, and maternal IQ. Models with measured childhood PFOA were additionally adjusted for child body mass index.

Results: Children in the highest as compared with lowest quartile of estimated in utero PFOA had increases in Full Scale IQ (β 4.6, 95% confidence interval [CI] = 0.7-8.5) and decreases in characteristics of attention deficit/hyperactivity disorder as measured by the Clinical Confidence Index of Connors' Continuous Performance Test-II (β -8.5, 95% CI = -16.1 to -0.8). There were negligible associations between PFOA and reading or math skills or neuropsychological functioning.

Conclusion: These results do not suggest an adverse association between the levels of PFOA exposure experienced by children in this cohort and their performance on neuropsychological tests.

Citing Articles

Effects of Early-life PFAS Exposure on Child Neurodevelopment: A Review of the Evidence and Research gaps.

Ames J, Sharma V, Lyall K Curr Environ Health Rep. 2025; 12(1):9.

PMID: 39888511 PMC: 11785707. DOI: 10.1007/s40572-024-00464-5.


Adverse outcome pathway for the neurotoxicity of Per- and polyfluoroalkyl substances: A systematic review.

Li S, Qin S, Zeng H, Chou W, Oudin A, Kanninen K Eco Environ Health. 2024; 3(4):476-493.

PMID: 39605965 PMC: 11599988. DOI: 10.1016/j.eehl.2024.08.002.


Relative risks of childhood developmental vulnerabilities in three Australian communities with exposure to per- and polyfluoroalkyl substances: data linkage study.

Di Law H, Armstrong B, DEste C, Hosking R, Smurthwaite K, Trevenar S Int J Popul Data Sci. 2024; 9(1):2180.

PMID: 38476271 PMC: 10929706. DOI: 10.23889/ijpds.v9i1.2180.


Effects of chronic home radon exposure on cognitive, behavioral, and mental health in developing children and adolescents.

Taylor B, Pulliam H, Smith O, Rice D, Johnson H, Coutant A Front Psychol. 2024; 15:1330469.

PMID: 38469220 PMC: 10925658. DOI: 10.3389/fpsyg.2024.1330469.


Prenatal and perinatal exposure to Per- and polyfluoroalkyl substances (PFAS)-contaminated drinking water impacts offspring neurobehavior and development.

Marchese M, Zhu T, Hawkey A, Wang K, Yuan E, Wen J Sci Total Environ. 2024; 917:170459.

PMID: 38290673 PMC: 10923173. DOI: 10.1016/j.scitotenv.2024.170459.


References
1.
Fei C, McLaughlin J, Lipworth L, Olsen J . Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect. 2008; 116(10):1391-5. PMC: 2569100. DOI: 10.1289/ehp.11277. View

2.
Power M, Webster T, Baccarelli A, Weisskopf M . Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey. Neuroepidemiology. 2012; 40(2):125-32. PMC: 3658136. DOI: 10.1159/000342310. View

3.
Bellinger D . The protean toxicities of lead: new chapters in a familiar story. Int J Environ Res Public Health. 2011; 8(7):2593-628. PMC: 3155319. DOI: 10.3390/ijerph8072593. View

4.
Tao L, Kannan K, Wong C, Arcaro K, Butenhoff J . Perfluorinated compounds in human milk from Massachusetts, U.S.A. Environ Sci Technol. 2008; 42(8):3096-101. DOI: 10.1021/es702789k. View

5.
Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, Stewart B . Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res. 2008; 108(1):56-62. DOI: 10.1016/j.envres.2008.06.001. View